| MR编号 | NL/H/0856/002 |
|---|
| 药品名称 | PIPERACILLINE/TAZOBACTAM SANDOZ 4 G/500 MG |
|---|
| 活性成分 | - piperacillin 4.0 g
- tazobactam 500.0 mg
|
|---|
| 剂型 | Powder for solution for injection |
|---|
| 上市许可持有人 | Sandoz BV
Almere, The Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Denmark (DK)
- Belgium (BE)
PIPERACILLINE/TAZOBACTAM Sandoz 4g/500mg Powder for solution for injection - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Piperacillin/Tazobactam Sandoz 4,0 g/0,5 g - Pulver zur Herstellung einer Injektions- oder Infusi - France (FR)
- Spain (ES)
- Italy (IT)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
Piperacillin/Tazobactam Sandoz 4000/500mg milteliai injekciniam/infuziniam tirpalui - Estonia (EE)
PIPERACILLIN/TAZOBACTAM SANDOZ 4000/500MG - Hungary (HU)
Piperacillin/Tazobactam Sandoz 2,25-4,5 mg por injekcióhoz - Slovakia (SK)
Piperacilin comp. Sandoz 4 g/ 0,5 g prášok na injekčný/ infúzny roztok - Sweden (SE)
|
|---|
| 许可日期 | 2008/08/14 |
|---|
| 最近更新日期 | 2023/10/25 |
|---|
| 药物ATC编码 | - J01CR05 piperacillin and beta-lactamase inhibitor
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|